July 18, 2016 / 5:11 AM / in a year

BRIEF-Pharming Group announces positive results from a phase 2 clinical study of RUCONEST

July 18 (Reuters) - Pharming Group NV

* Announced positive results from a phase 2 clinical study of RUCONEST

* Announces positive results from randomized controlled trial with RUCONEST for HAE Prophylaxis

* Pharming will receive an undisclosed milestone payment from Valeant as and when FDA approval for this additional indication is given Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below